HomeBCLI • NASDAQ
add
Brainstorm Cell Therapeutics Inc
Previous close
$1.13
Day range
$1.12 - $1.22
Year range
$0.72 - $8.09
Market cap
9.69M USD
Avg Volume
2.34M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.09M | 24.86% |
Net income | -2.86M | 15.79% |
Net profit margin | — | — |
Earnings per share | -0.45 | — |
EBITDA | -3.03M | -25.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.64M | 111.04% |
Total assets | 3.57M | 6.66% |
Total liabilities | 11.03M | 23.94% |
Total equity | -7.46M | — |
Shares outstanding | 7.91M | — |
Price to book | -1.20 | — |
Return on assets | -285.86% | — |
Return on capital | 124.25% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.86M | 15.79% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2000
Website
Employees
27
